Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Dutasteride and finasteride affect different cell types differently.

Finasteride negatively affects fish reproduction and gonadal development.

A genetic marker linked to a type of hair loss was found in most patients studied.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

New tests detect finasteride and dutasteride in urine quickly and easily.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.